September 24, 2021 by Chain Drug Review
Walgreens
Leading Headlines, Pharmacy
DEERFIELD, Ill. — Walgreens announced on Friday that eligible individuals can now receive Pfizer COVID-19 booster vaccinations in stores nationwide, following Food and Drug Administration (FDA) Emergency Use Authorization and new guidance from the Centers for Disease Control and Prevention (CDC). “Walgreens has played a vital role in responding to COVID-19 as millions have turned
September 24, 2021 by Chain Drug Review
Rite Aid, Uber Eats
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid Corp. announced on Friday the expansion of their partnership with Uber Technologies to offer delivery of Rite Aid products nationwide through Uber Eats. This partnership will allow customers to conveniently order and receive essential healthcare and grocery items directly to their homes. On-demand delivery is now available for 2,185 Rite Aid
September 24, 2021 by Chain Drug Review
Wahl
Supplier News
STERLING, Ill.– Need proof that life is better with a beard? The second-annual ‘Most Talented Beard in America’ contest is just one example. Men’s grooming leader Wahl knows there’s a wealth of whiskered talent out there, so the company is once again looking to reward furry phenoms. Bearded hopefuls from across America submitted videos of their talents,
September 24, 2021 by Chain Drug Review
Costco
Business, Leading Headlines, Retail News
ISSAQUAH, Wash. — Costco Wholesale Corp. on Thursday evening reported fourth-quarter earnings that beat Wall Street expectations. The warehouse club operator said its net income for the fourth quarter ended August 29 totaled $1.67 billion, or $3.76 per diluted share. That compared to $1.39 billion, or $3.13, last year. Wall Street had been expecting earnings
September 23, 2021 by Chain Drug Review
CDC, COVID-19 booster shots
Leading Headlines, Pharmacy
NEW YORK — A Centers for Disease Control and Prevention advisory panel on Thursday voted to recommend a third Pfizer-BioNTech COVID-19 shot for those over 65 and certain groups with underlying medical conditions. In a series of votes, the Advisory Committee on Immunization Practices said it favored booster shots at least six months after the standard
September 23, 2021 by Chain Drug Review
Aurobindo Pharma
Pharmacy, Supplier News
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application fenofibrate capsules USP, 67mg, 134mg, and 200mg. Aurobindo Pharma’s fenofibrate capsules USP, 67mg, 134mg, and 200mg are an AB-rated generic equivalent to the reference listed drug (RLD), Tricor Capsules of AbbVie.
September 23, 2021 by Chain Drug Review
Hello Products, TerraCycle
Leading Headlines, Supplier News
MONTCLAIR, N.J. – Personal care recycling just got more friendly as Hello Products announced its highly-anticipated partnership with international recycling leader TerraCycle. Beginning September 22nd, Hello will be part of the Natural Care Recycling Program, which offers a free and easy way to recycle your favorite personal care products like mouthwash bottles and caps, toothbrushes,
September 23, 2021 by Chain Drug Review
COVID-19 booster shots, Meijer, Meijer president and chief executive officer Rick Keyes
Leading Headlines, Pharmacy, Retail News
GRAND RAPIDS, Mich. — Meijer said Thursday that it is ready to administer COVID-19 booster shots to eligible patients – regardless of where they received their original vaccine series – at all its pharmacies across the Midwest. “We’ve come a long way these past 18 months, but in order to continue on that path and
September 23, 2021 by Chain Drug Review
The Nos Inspiras Tú, Unilever
Leading Headlines, Supplier News
ENGLEWOOD CLIFFS, N.J. — Unilever is launching a campaign during Hispanic Heritage Month that pays homage to the contributions of U.S. Hispanics, the company said on Thursday. The Nos Inspiras Tú (You are our Inspiration) cites Hispanics’ sense of community, pride of heritage, entrepreneurial spirit and commitment to progress as a source of inspiration for Unilever and
September 23, 2021 by Chain Drug Review
Walmart
Leading Headlines, Retail News
BENTONVILLE, Ark. — Walmart Inc. said Thursday that it has closed its previously announced $2 billion inaugural green bond offering. Net proceeds will be allocated to fund current and prospective projects to advance Walmart’s sustainability goals. The green bond is Walmart’s first offering under the company’s Green Financing Framework, published August 2021, which details the
September 23, 2021 by Chain Drug Review
Coalition for PBM Reform
Leading Headlines, Pharmacy
WASHINGTON — Six national organizations who counsel patients, treat patients, advocate for patients, or provide prescription drug benefits to employees and their families joined forces today in a new coalition aimed at bringing transparency to a part of the health care system dominated by a few giant corporate middlemen but which very few people understand.
September 23, 2021 by Chain Drug Review
Hartig Drug Co., Scott Roth
Leading Headlines, Pharmacy
DUBUQUE, Iowa – Hartig Drug Co. announces a location move for managing pharmacist Scott Roth to Hartig Drug in Platteville, Wisconsin. Roth graduated from the School of Pharmacy at the University of Wisconsin-Madison. He was previously the pharmacy manager at the Hartig Drug on Central Avenue in Dubuque, Iowa. Roth is responsible for overseeing the
September 23, 2021 by Chain Drug Review
Heyward Donigan, Rite Aid Corp.
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. on Thursday reported a narrower than expected second quarter loss. The company reported a net loss of $100.3 million, or $1.86 per share for the period ended August 28. The adjusted net loss was $22 million, or 41 cents per share. Analysts had forecast an adjusted net loss
September 23, 2021 by Chain Drug Review
FDA, Pfizer COVID booster shot
Leading Headlines, Pharmacy
WASHINGTON — The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer and BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus. The decision paves the way for a quick rollout of the booster